Private Eye

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Off-market insider buying at Spectral Medical (T:EDT)

Updated Tuesday Aug 03, 2021 02:06 AM EDT

Anthony Phillip Bihl, a Director, acquired 423,530 Common Shares on a direct ownership basis at a price of $0.425 through a prospectus or prospectus exempt offering on July 27th, 2021. The insider also acquired 211,765 Warrants on a direct ownership basis with an exercise price of $0.500 for 36 months. This represents a $180,000 investment into the company's shares and an account share holdings change of 73.7%.

Two other insiders also reported participating in smaller amounts. 

Spectral Medical is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Spectral Medical Inc. is a late stage theranostic company advancing therapeutic options for sepsis and septic shock. The Company has developed a product for the treatment of patients with septic shock, Toraymyxin (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company's Endotoxin Activity Assay (EAA). The EAA is a rapid in-vitro diagnostic test that measures negative bacterial cell wall (endotoxin) activity in a whole blood sample. The Company, through its wholly owned subsidiary, Dialco Medical Inc. (Dialco), is also commercializing a new platform, SAMI. Its platform is targeting the renal replacement therapy (RRT) market.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
Rain
Rain
Rain
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to Spectral Medical Inc. (EDT)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $EDT.CA

  • No tweets found

Stocktwits